Kobayashi Ayako, Higashi Hideaki, Shimada Tomoe, Suzuki Satowa
Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Infect Prev Pract. 2023 Feb 11;5(2):100272. doi: 10.1016/j.infpip.2023.100272. eCollection 2023 Jun.
Outbreaks of bloodstream infections (BSIs) are a concern in Japanese medical settings.
This study determined baseline values for detection in clinical samples that are useful as reference values for hospitals when assessing the need for intervention.
A retrospective analysis of detection in the Japan Nosocomial Infections Surveillance data from 2008 to 2014 was performed; it included 950 individual hospitals across the country.
spp. were detected in 0.54% of the clinical specimens submitted for bacteriological testing. Specimens positive for spp. were mainly blood (24.6%), stool (26.5%), and respiratory specimens (23.3%). Identification of spp. at the species level (i.e., or ) was reported in 55.3%, 14.7%, and 15.4% of cases, of which 88.9%, 48.3%, and 33.1% were in blood, stool, and respiratory specimens, respectively. Of the 4105 hospital-years, 75.7% had blood specimens with spp., with a median of 0.85 blood specimens/100 beds annually (interquartile range, 0.17-2.10). The detection showed significant summer seasonality, regardless of specimen type or geographic distribution. The detection did not show seasonality, and its detection remained constant throughout the year. The seasonality of spp. reflects the high proportion of .
The increased detection rate of spp. during summer should be interpreted as a risk factor for BSIs. A post-summer decrease in spp. should not be interpreted as an effect of interventions.
血流感染(BSIs)的爆发在日本医疗环境中备受关注。
本研究确定了临床样本检测的基线值,这些值在医院评估干预需求时可作为参考值。
对2008年至2014年日本医院感染监测数据中的检测情况进行回顾性分析;该数据涵盖全国950家医院。
在提交进行细菌学检测的临床标本中,[具体菌种]的检出率为0.54%。[具体菌种]阳性标本主要为血液(24.6%)、粪便(26.5%)和呼吸道标本(23.3%)。在55.3%、14.7%和15.4%的病例中分别报告了[具体菌种]在种水平的鉴定(即[具体菌种1]或[具体菌种2]),其中血液、粪便和呼吸道标本中分别有88.9%、48.3%和33.1%为[具体菌种]。在4105个医院年中,75.7%有含[具体菌种]的血液标本,每年每100张床位含[具体菌种]血液标本的中位数为0.85份(四分位间距为0.17 - 2.10)。[具体菌种1]的检出呈现明显的夏季季节性,与标本类型或地理分布无关。[具体菌种2]的检出无季节性,全年检出率保持恒定。[具体菌种1]的季节性反映了[相关因素]的高比例。
夏季[具体菌种1]检出率的增加应被视为血流感染的一个危险因素。夏季过后[具体菌种1]检出率的下降不应被解释为干预措施的效果。